Global Agriculture Biotech Market Anticipated to Garner $214.6 Billion, Growing with 8.8% CAGR in the 2022-2031 Timeframe [270-Pages] | Commended by Research Dive
March 09, 2023 09:00 ET | Research Dive
New York, USA, March 09, 2023 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global agriculture biotech market. According to the report, the global market is projected to...
Gastric Cancer Diagnostic Procedure Market Size Forecasts at 6.5% CAGR during (2022-2028) - Deep Dive Analysis of 18+ Countries across 5 Key Regions, 50+ Companies Scrutinized | The Insight Partners
March 02, 2023 09:55 ET | The Insight Partners
New York, March 02, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Gastric Cancer Diagnostic Procedure Market Size, Share, Growth, Trends and Global Forecasts to 2028 - COVID-19 Impact...
DBMR Logo.png
Molecular Diagnostics Market Size worth USD 46.65 Billion with Registering a CAGR of 12.8% by 2029, Size, Share, Demand, Rising Trends and Competitive Outlook
February 15, 2023 03:30 ET | Data Bridge Market Research
BIRMINGHAM, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Molecular Diagnostics Market study by "Data Bridge Market Research" provides details about the market dynamics affecting this market, Market scope,...
Future Market Insights.png
Point-of-care Molecular Diagnostics Market to reach $11.1 billion by 2033, Get ahead of the Competition with future market Insights, Inc.
January 30, 2023 03:30 ET | Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Jan. 30, 2023 (GLOBE NEWSWIRE) -- The Point-Of-Care Molecular Diagnostics Market is predicted to secure a valuation of US$ 4.4 billion in 2023 and is rising to US$ 11.1 billion by 2033....
Dyadic Logo Current.jpg
Dyadic Announces Sale of Equity Interest in Alphazyme
January 19, 2023 08:30 ET | Dyadic International, Inc.
JUPITER, Fla., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Contrive Datum Insights_Logo.jpg
In Vitro Cancer Diagnostics Market Is Expected To Grow at a CAGR Of 3.9% during Forecast Period 2023 To 2030 | Data By Contrive Datum Insights Pvt Ltd.
January 13, 2023 13:07 ET | Contrive Datum Insights Pvt Ltd
Farmington, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The Global In-vitro Cancer Diagnostic Market is expected to grow at a CAGR of 3.9% during the forecasting period 2023-2030. Cancer is the growth of...
BioGX Launches 'pixl™' Portable qPCR Platform Ex-US With Expanded Test Menu for Infectious Diseases
December 08, 2022 14:00 ET | BioGX Inc.
BIRMINGHAM, Ala., Dec. 08, 2022 (GLOBE NEWSWIRE) -- BioGX, a global provider of easy molecular diagnostic solutions since 2007, announced the Ex-US commercial release of its portable pixl™ qPCR...
Meticulous Logo.png
Point-of-Care Diagnostics Market Worth $82.74 Billion by 2029 - Exclusive Report by Meticulous Research®
November 22, 2022 09:00 ET | Meticulous Market Research Pvt. Ltd.
Redding, California, Nov. 22, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, COVID-19, TB, HAI,...
visiongain Logo.png
Global Molecular Diagnostics Market is projected to grow at a CAGR of 7.28% by 2032: Visiongain Reports Ltd
November 17, 2022 06:00 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled Molecular Diagnostics Market 2022-2032. It includes profiles of Molecular Diagnostics Market and Forecasts Market Segment by Market Segment by Type...
Press release Biocartis Group NV: Biocartis launches a rights offering (with extra-legal preferential rights for existing shareholders) of a maximum of 33,476,932 offered shares, amounting to a maximum of EUR 25,107,699.00
November 16, 2022 01:00 ET | Biocartis NV
ADVERTISEMENT PRESS RELEASE: INSIDE INFORMATION / REGULATED INFORMATION 16 November 2022, 07:00 CET Biocartis launches a rights offering (with extra-legal preferential rights for existing...